Dr. Kimberly Page, Ph.D., MPH is an infectious disease epidemiologist whose research has focused on hepatitis C virus (HCV) and HIV infections in multiple high risk populations. She has led prospective cohort studies, clinical trials and implementation science research. She is a Distinguished Professor of Epidemiology, Biostatistics and Preventive Medicine, in the Department of Internal Medicine at the University of New Mexico Health Sciences Center. Dr. Page is the PI of the NIDA Southwest Clinical Trials Network Node which aims to advance NIDA’s goals of expanding research to further the field of promising science-based prevention and treatment delivery to people patients with substance use disorders in a variety of treatment settings and with diverse populations.